Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/27199
Title: Disrupting iron homeostasis can potentiate colistin activity and overcome colistin resistance mechanisms in Gram-Negative Bacteria
Authors: Gadar, K
de Dios, R
Kadeřábková, N
Prescott, TAK
Mavridou, DAI
McCarthy, RR
Keywords: antibiotics;antimicrobial resistance
Issue Date: 13-Sep-2023
Publisher: Springer Nature
Citation: McCarthy, R.R. et al. (2023) 'Disrupting iron homeostasis can potentiate colistin activity and overcome colistin resistance mechanisms in Gram-Negative Bacteria', Communications Biology, 6, 937, pp. 1 - 16. doi: 10.1038/s42003-023-05302-2.
Abstract: Copyright © The Author(s) 2023. Acinetobacter baumannii is a Gram-negative priority pathogen that can readily overcome antibiotic treatment through a range of intrinsic and acquired resistance mechanisms. Treatment of carbapenem-resistant A. baumannii largely relies on the use of colistin in cases where other treatment options have been exhausted. However, the emergence of resistance against this last-line drug has significantly increased amongst clinical strains. In this study, we identify the phytochemical kaempferol as a potentiator of colistin activity. When administered singularly, kaempferol has no effect on growth but does impact biofilm formation. Nonetheless, co-administration of kaempferol with sub-inhibitory concentrations of colistin exposes bacteria to a metabolic Achilles heel, whereby kaempferol-induced dysregulation of iron homeostasis leads to bacterial killing. We demonstrate that this effect is due to the disruption of Fenton’s reaction, and therefore to a lethal build-up of toxic reactive oxygen species in the cell. Furthermore, we show that this vulnerability can be exploited to overcome both intrinsic and acquired colistin resistance in clinical strains of A. baumannii and E. coli in vitro and in the Galleria mellonella model of infection. Overall, our findings provide a proof-of-principle demonstration that targeting iron homeostasis is a promising strategy for enhancing the efficacy of colistin and overcoming colistin-resistant infections.
Description: Data availability: Transcriptomics datasets obtained through this work have been deposited at the Gene Expression Omnibus (GEO) repository of National Centre for Biotechnology Information (NCBI) under the accession number GSE212989. Numerical source data is available in the Supplementary Data 3 file and all other data are available from the corresponding author on reasonable request.
Supplementary information is available online at https://www.nature.com/articles/s42003-023-05302-2#Sec30 .
URI: https://bura.brunel.ac.uk/handle/2438/27199
DOI: https://doi.org/10.1038/s42003-023-05302-2
Other Identifiers: ORCID iDs: Rubén de Dios https://orcid.org/0000-0001-6704-9149; Nikol Kadeřábková https://orcid.org/0000-0002-1205-1644; Despoina A. I. Mavridou https://orcid.org/0000-0002-7449-1151; Ronan R McCarthy https://orcid.org/0000-0002-7480-6352.
937
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © The Author(s) 2023. Rights and permissions: Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.2.76 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons